RPE cell senescence: A key contributor to age-related macular degeneration

Medical Hypotheses

Volumn 78, Issue 4, 2012, Pages 505-510

  Kozlowski, Michael R ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; COMPLEMENT FACTOR H; ESTROGEN; OMEGA 3 FATTY ACID; VASCULOTROPIN INHIBITOR; VITAMIN D; ZINC;

ARTICLE; CELL AGING; DRUSEN; FAT INTAKE; GEOGRAPHIC ATROPHY; HUMAN; OUTCOME ASSESSMENT; PIGMENT EPITHELIUM; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; RISK REDUCTION; SUBRETINAL NEOVASCULARIZATION; TRANSPLANTATION; VITAMIN SUPPLEMENTATION;

CELL AGING; CHOROIDAL NEOVASCULARIZATION; COMPLEMENT FACTOR H; DEAD-BOX RNA HELICASES; ESTROGENS; FATTY ACIDS, OMEGA-3; GEOGRAPHIC ATROPHY; HUMANS; MACULAR DEGENERATION; RETINAL DRUSEN; RETINAL PIGMENT EPITHELIUM; RIBONUCLEASE III; RISK FACTORS; VITAMIN D;

EID: 84858155866     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.01.018     Document Type: Article

References (93)

1. Global initiative for the elimination of avoidable blindness: Action plan 2006-2011 2007, WHO Press, Geneva, p 32-3.
2. Kanski J.J. Age-related macular degeneration. Clinical ophthalmology: a systemic approach 2007, Butterworth, Heinemann, Elsevier (NY), p. 23-9.
3. Alexander L.J. Primary Care of the Posterior Segment 2002, McGraw Hill, New York, p. 94-8. Third Edition.
4. Spaide R. Etiology of late-age-related macular disease. Age related macular degeneration: a comprehensive textbook 2006, 23-39. Lippincott, Williams and Wilkins, Philadelphia. D.V. Ilfara, P.E. Liggett, W.F. Mieler (Eds.).
5. Edwards A.O., Ritter R., Abel K.J. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
6. Christen W.G., Schaumberg D.A., Glynn R.J., et al. Dietary omega-3 fatty acid and fish intake and incident age-related macular degeneration in women. Arch Ophthalmol 2011, 129:921-929.
7. Millen A.E., Voland R., Sondel S.A., et al. Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol 2011, 129:481-489.
8. Parekh N., Chappell R.J., Millen A.M., et al. Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Arch Ophthalmol 2007, 125:661-669.
9. Feshanich D., Cho E., Shaumberg D.A., et al. Menopausal and reproductive factors and risk of age-related macular degeneration. Arch Ophthalmol 2008, 126:519-524.
10. Fraser-Bell S., Wu J., Klein R., et al. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino eye study. Am J Ophthalmol 2006, 141:79-87.
11. Knudtson M.D., Klein R., Klein B.E.K. Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Br J Ophthalmol 2006, 90:1461-1463.
12. Thompson W. Classification of age-related macular degeneration. Age related macular degeneration: a comprehensive textbook 2006, 44-52. Lippincott, Williams and Wilkins, Philadelphia. D.V. Ilfara, P.E. Liggett, W.F. Mieler (Eds.).
13. Sparrow J.R., Fishkin N., Zhou J., et al. A2E, a byproduct of the visual cycle. Vis Res 2003, 43:2983-2990.
14. Nickla D.L., Wallman J. The multifunctional choroid. Prog Retinal Eye Res 2011, 29:144-168.
15. Zipfel PF, Lauer N, Skerka C. The role of complement in AMD. In: Lambris JD, Adamis AP, editors. Inflammation and retinal disease: complement biology and pathology, New York: Springer; 2010. p. 9-24.
16. Haines J.L., Huaser M.A., Schmidt S., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
17. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
18. Sepp T., Khan J.C., Thurlby D.A., et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci 2006, 47:536-540.
19. Kaneko J., Dridi S., Tarallo V., et al. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 2011, 471:325-330.
20. Age-related eye disease study research group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 2001, 119:1417-1436.
21. Ciulla T.A., Rosenfeld P.J. Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration. Curr Opin Ophthalmol 2009, 20:158-165.
22. Zhang K., Hopkins J.J., Heier J.S., et al. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci USA 2011, 108:6241-6245.
23. Slakter J. Two-year analysis of the efficacy and safety of fenretinide vs. Placebo in the treatment of geographic atrophy. Presented at the American Academy of Ophthalmology Meeting, Chicago (IL); 2010 [Program Number: PA024].
24. Binder S. Human retinal transplantation. Age related macular degeneration: a comprehensive textbook 2006, 314-327. Lippincott, Williams and Wilkins, Philadelphia. D.V. Ilfara, P.E. Liggett, W.F. Mieler (Eds.).
25. Zarbin M.A. Retinal pigment epithelium - retina transplantation for retinal degenerative disease. Am J Ophthalmol 2008, 146:151-152.
26. Lu B. Malcuit, C, Wang, S. et al. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009, 27:2126-2135.
27. Rodier R., Campisi J. Four Faces of Cellular Senscence. J Cell Biol 2011, 192:547-556.
28. Sanin E., DePinho R.A. Linking functional decline of telomeres, mitochondria and stem cells during aging. Nature 2010, 464:520-528.
29. Burton D.G.A. Cellular senescence, ageing and disease. Age 2009, 31:1-9.
30. Minamino T., Komuro I. Vascular cell senescence contribution to atherosclerosis. Circ Res 2007, 100:15-26.
31. Valdes A.M., Richards J.B., Gardner J.P., et al. Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis. Osteoporos Int 2007, 18:1203-1210.
32. Shelton D.N., Chang E., Whittier P.S., et al. Microarray analysis of replicative senescence. Curr Biol 1999, 9:939-945.
33. Matsunaga H., Handa J.T., Aotaki-Keen A., et al. Beta-galactosidase histochemistry and telomere loss in senescent retinal pigment epithelial cells. Ophthalmol Vis Sci 1999, 40:197-202.
34. Mishima K., Handa J.T., Aotaki-Keen A., et al. Senescence-associated beta-galactosidase histochemistry for the primate eye. Invest Ophthalmol Vis Sci 1999, 40:1590-1593.
35. Ren J.-L., Pan J.-S., Lu Y.-P., et al. Inflammatory signaling and cellular senescence. Cell Sig 2009, 21:378-383.
36. von Zglinicki T., Saretzki G., Docke W., et al. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: A model for senescence?. Exp Cell Res 1995, 220:186-193.
37. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing in human fibroblasts. Nature 1990, 345:458-460.
38. Weng N.-P., Levine B.L., June C.H., et al. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996, 183:2471-2479.
39. Hu H., Belcher M., van der Harst P. Healthy aging and disease: Role for telomere biology?. Clinical Science 2011, 120:427-440.
40. Hwang E.S., Yoon G., Kang H.T. A comparative analysis of the cell biology of senescence and aging. Cell Mol Life Sci 2009, 66:2503-2524.
41. Kurz D.J., Decary S. Hong. Y. et al. Senescence-associated beta-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci 2000, 113:3613-3622.
42. Iyer M., Mieler W.F. Differential diagnosis of age-related macular degeneration. Age related macular degeneration: a comprehensive textbook 2006, 72-75. Lippincott, Williams and Wilkins, Philadelphia. D.V. Ilfara, P.E. Liggett, W.F. Mieler (Eds.).
43. Coppe J.-P., Kauser K., Campisi J., et al. Secrection of vascular endothelial growth factor by primary human fibroblasts at senescence. J Biol Chem 2006, 281:29568-29574.
44. Ksiazek K. Senscent human peritoneal cells promote proliferation of ovarian cancer cells in vitro through a VEGF-dependent pathway 2007, SENS 3 Conference.
45. Del Priore L.V., Kuo Y.-H., Tezel T.H. Age-related changes in human RPE cell density and apoptosis proportion in situ. Invest Ophthalmol Vis Sci 2002, 43:3312-3318.
46. Organesian A., Bueno E., Yan Q., et al. Scanning and transmission electron microscopic findings during RPE would healing in vivo. Int Ophthalmol 1997, 21:165-175.
47. Roider J., Michaud N.A., Flotte T.J., et al. Response of the retinal pigment epithelium to selective photocoagulation. Arch Ophthalmol 1992, 110:1786-1792.
48. Niu S., Matsuda T. Endothelial cell senescence inhibits unidirectional endothelialization in vitro. Cell Transplant. 1992, 1:355-364.
49. Garfinkel S., Hu X. Prudovsky, I.A et al. FGF-1-dependant proliferative and migratory responses are impaired in senescent human umbilical vein endothelial cells and correlate with the inability to signal tyrosine phosphorylation of fibroblast growth factor receptor-1 substrates. J Cell Biol 1996, 134:783-791.
50. Wang L., Clark M.E., Crossman D.K., et al. Abundant lipid and protein components of drusen. PLoS ONE 2010, 5(4):e10329.
51. Cuervo A.M., Dice J.F. When lysosomes get old. Exper Gerontol 2000, 35:119-131.
52. Bandyopadhyay D., Medrano E.E. Aging and senescence of melanocytes. The pigmentary system 2006, 464-471. Blackwell Publishing, Malden (MA). 2nd ed. J.J. Norlund, R.E. Boissy, V.J. Hearing (Eds.).
53. Seddon J.M., Rosner B., Sperduto R.D., et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 2001, 119:1191-1199.
54. Farzaneh-Far R., Lin J., Epel E.S., et al. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 2010, 303:250-257.
55. Bayne S., Jones M.E.E., Li H., et al. Estrogen deficiency leads to telomerase inhibition, telomere shortening and reduced cell proliferation in the adrenal gland of mice. Cell Res 2008, 18:1141-1150.
56. Richards J.B., Valdes A.M. Gardner, J.P et al. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am J Clin Nutr 2007, 86:1420-1425.
57. Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol 2009, 9:729-740.
58. Mammone T., Gan D., Foyouzi-Youseffi R. Apoptotic cell death increases with senescence in normal human dermal fibroblast cultures. Cell Biol Int 2006, 30:903-909.
59. Daniel C., Wagner A., Hohenstein B., et al. Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activitation. Am J Physiol Renal Physiol 2009, 297:F1299-F1309.
60. Lange-Asschenfeldt B., Weninger W., Velasco P., et al. Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity elicited in the skin of thrombospondin-2 deficient mice. Blood 2002, 99:538-545.
61. Jaronczyk K., Carmichael J.B., Hobman T.C. Exploring the functions of RNA interference pathway proteins: Some functions more RISCy than others?. Biochem J 2005, 387:561-571.
62. Marasa B.S., Srikantan S., Masuda K., et al. Increased MKK4 abundance with replicative senescence is linked to joint reduction of multiple microRNAs. Sci Signal 2009, 2:ra69.
63. Mudhasani R., Zhu Z., Hutvagner G., et al. Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells. J Cell Biol 2008, 181:1055-1063.
64. Samani N.S., Boultby R. Butler, R. et al. Telomere shortening in atherosclerosis. Lancet 2001, 358:472-473.
65. Salpea K.D., Humphries S.E. Telomere length in atherosclerosis and diabetes. Atherosclerosis 2010, 209:35-38.
66. Fuster J.J., Diez J., Andres V. Telomere dysfunction in hypertension. J Hypertens 2007, 25:2185-2192.
67. Lung F.-W., Ku C.-S., Kao W.-T. Telomere length may be associated with hypertension. J Human Hypertens 2008, 22:230-232.
68. Likens N., Deerlin V.V., Clark C.M., et al. Comparisons of telomere length in peripheral blood and cerebellum in Alzheimer's disease. Alzheimer's and Dementia 2009, 5:463-469.
69. Panossian L.A., Porter V.R., Valenzuela H.F., et al. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 2003, 24:77-84.
70. Franco S., Blasco M.A., Sidlak S.L., et al. Telomeres and telomerase in Alzheimer's diease: Epiphenomena or a new focus for therapeutic strategy?. Alzheimer's and Dementia 2006, 2:164-168.
71. Kim S., Parks C.G., DeRoo L.A., et al. Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev 2009, 18:816-820.
72. Valdes A.M., Andrew T., Gardner J.P., et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005, 366:662-664.
73. Cassidy A., De Vivo A., Liu Y., et al. Associations between diet, lifestyle factors, and telomere length in women. Am J Clin Nutr 2010, 91:1273-1280.
74. Pavanello S., Hoxha M., Dioni L., et al. Shortened telomeres in individuals with abuse in alcohol consumption. Int J Cancer 2011, 129:983-992.
75. McGrath M., Wong J.Y.Y., Michaud D., et al. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007, 16:815-819.
76. Mirabello L., Huang W.-Y., Wong J.Y.Y., et al. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell 2009, 8:405-413.
77. Moria M., Busquets X., Pons J., et al. Telomere shortening in smokers with and without COPD. Eur Respir J 2006, 27:525-528.
78. Klein R., Cruickshanks K.J., Klein B.E.K., et al. Is age-related maculopathy related to hearing loss?. Arch Ophthalmol 1998, 116:360-365.
79. Darrat I., Ahmad N., Seldman K., et al. Auditory research involving antioxidants. Curr Opin Otolaryngol Head Neck Surg 2007, 15:358-363.
80. Werner C., Furster T., Widmann T., et al. Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall. Circulation 2009, 120:2438-2447.
81. Zhu H., Wang X., Gutin B., et al. Leukocyte telomere length in healthy Caucasian and African-American adolescents: Relationship with race, sex, adiposity, adipokines, and physical activity. J Pediatr 2011, 158:215-220.
82. Nordfjall K., Larefalk A., Lindren P., et al. Telomere length and heredity: Indications of paternal inheritance. Proc Nat Acad Sci USA 2005, 102:16374-16378.
83. Pinkhasov R.M., Shteynshlyuger A., Hakimian P., et al. Are men shortchanged on health? Perspective of life expectancy, morbidity, and mortality in men and women in the United States. Int J Clin Pract 2010, 64:465-474.
84. Eaton E.M. Fenretinide treatment of geographic atrophy in dry AMD: preliminary results. Retina Today 2010, 10:57-58.
85. Nemoto K., Kondo Y., Himeno S., et al. Modulation of telomerase activity by zince in human prostatic and renal cancer cells. Biochem Pharmacol 2000, 59:401-405.
86. The CATT Research Group Ranibizumab and Bevacizumab for neovascular age-related macular degeneration. New Engl J Med 2011, 364:1897-1908.
87. Vergara C., Ramirez B. CNTF, a pleiotropic cytokine: emphasis on its myotrohic role. Brain Res Rev 2004, 47:161-173.
88. Yamgiwa Y., Meng F., Patel T. Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes. Life Sci 2006, 78:2494-2502.
89. Burke J.M., Soref C. Topographical variation in growth in cultured bovine retinal pigment epithelium. Invest Ophthalmol Vis Sci 1988, 29:1784-1788.
90. Rastmanesh R. Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity. Medical Hypotheses 2011, 76:79-85.
91. Harley C.B., Liu W., Blasco M., et al. A natural product telomerase activator as part of a health maintenance program. Rejuv Res 2011, 14:45-56.
92. Fauce S.R., Jamieson B.D., Chin A.C., et al. Telomerase-based pharmacological enhancement of antiviral function of human CD8+ T lymphocytes. J Immunol 2008, 181:7400-7408.
93. Artandi S.E., DePinho R.A. Telomeres and telomerase in cancer. Carcinogenesis 2010, 31:9-18.